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9th February 2017 
 
Dear Editor, 
 
In reply to “Hynes S.O. et al. Back to the future: routine morphological assessment of the 
tumour microenvironment is prognostic in stage II/III colon cancer in a large population-
based study” 
 
We read with interest the recent study by Hynes et al 1.  In this study of 445 patients undergoing 
surgical resection of stage II/III colon cancer, the presence of a conspicuous peritumoural 
inflammatory cell infiltrate, as measured by the Crohn’s like reaction (CLR) and a modification 
of the Klintrup-Mäkinen grade (examining only the lymphoid cell population), was associated 
with improved prognosis.  A high proportion of tumour-associated stroma, as measured by a 
‘global’ assessment of the tumour stroma percentage (TSP) but not ‘focal’ assessment, was also 
associated with poorer survival.  The CLR and global assessment of TSP demonstrated 
acceptable levels of inter- and intraobserver variability, whereas the peritumoural lymphoid 
infiltrate and focal TSP assessment did not.  Identifying the complimentary prognostic value of 
both the inflammatory infiltrate and the TSP, the authors proposed a combined 
‘fibroinflammatory score’, which stratified survival independent of stage, MSI status and 
chemotherapy use. 
 
We however wish to raise a number of points for consideration.  Acknowledging that it is the 
lymphoid population that holds most prognostic value within the inflammatory infiltrate, the 
proposed modification of the Klintrup-Mäkinen grade has not been validated as a reliable and 
reproducible measure.  Although encompassing all inflammatory cell types, the original Klintrup-
Mäkinen grade has been validated internationally as a reproducible, stage-independent 
characteristic in colorectal cancer 2, 3.  Therefore, it would be more readily  
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applicable in routine clinical practice.  Furthermore, given the high degree of interobserver 
variability of the modified Klintrup-Mäkinen grade, assessment of specific lymphoid populations 
may require immunohistochemical staining for immune cell subsets.  The Immunoscore, 
reflective of CD3+ and CD8+ T-lymphocyte density, is one such example4.  
 
Hynes and colleagues employed semi-quantitative assessment of the CLR as described by 
Graham and Appelman, however it has recently been reported that more objective assessment of 
lymphoid follicle density or size increases not only reproducibility, but also prognostic value 5.  
Similarly, although not associated with survival, it is of interest that the ‘focal’ assessment of 
TSP reflects a refinement of the previously described ‘global’ assessment, and again has 
previously been internationally validated in the context of retrospective analysis of clinical trial 
data 6, 7. 
 
Finally, although the authors must be congratulated on further supporting the routine use of both 
the inflammatory infiltrate and stroma to inform prognosis of patients with colorectal cancer, the 
presently described ‘fibroinflammatory score’ is not the first tumour microenvironment score to 
consider combined assessment of both elements.  Several groups have recognised the relative 
importance of both the inflammatory infiltrate and tumour-associated stroma; ranging from the 
Jass criteria described in 1986 8, to the more recently described consensus molecular subtypes 
associated with distinctive tumour microenvironment phenotypes 9.   
Recently, we have described a tumour microenvironment score based on combined assessment of 
the Klintrup-Mäkinen grade and TSP 10.  This score, termed the Glasgow Microenvironment 
Score (GMS), stratified survival independent of stage, mismatch repair status and chemotherapy 
use.  The GMS also allows further insight into the evolution of the tumour microenvironment; a 
high TSP was rare and had no prognostic value in the presence of a high Klintrup-Mäkinen grade, 
only stratifying survival of those with a low density inflammatory infiltrate. These results were 
similarly observed when examining the combined prognostic value of the Immunoscore and TSP 
11.  Taken together, we believe these results suggest that it is loss of the anti-tumour inflammatory 
infiltrate that promotes development of the tumour-associated stroma.  Given the reliance of the 
GMS on validated, readily  
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reproducible assessments, and its utilisation of routine pathological specimens, we would 
encourage the authors of the present study to adopt a similar approach to assessment of the 
tumour microenvironment in patients with colorectal cancer. 
Yours sincerely, 
 
Mr James Park, Clinical Lecturer in Colorectal Surgery 
Dr Campbell Roxburgh, Senior Clinical Lecturer 
Dr Joanne Edwards, Senior Lecturer 
Professor Paul Horgan, Professor of Surgery 
Professor Donald McMillan, Professor of Surgical Sciences 
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